Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 38 min ago
PreprintCC BYbioRxiv

Differential requirement for the Ire1 luminal domain in Candida albicans drug susceptibility and pathogenicity

  1. 1Western University

Abstract

The opportunistic human pathogen Candida albicans depends on the unfolded protein response (UPR) for cell wall integrity, antifungal tolerance, filamentous growth, and virulence. The UPR is driven by the conserved transmembrane sensor Ire1, which is activated either by misfolded proteins through its luminal domain or by lipid bilayer stress (LBS) through its transmembrane domain. In budding yeast, these two activation modes deploy divergent transcriptional programs. Whether the requirement for these two input domains is separable in C. albicans, where the cell membrane and cell wall are themselves the targets of major antifungal drug classes, remains unknown. Here, we engineered a C. albicans strain expressing Ire1 lacking an intact luminal domain (ire1{Delta}LD), which no longer detects proteotoxic stress. The ire1{Delta}LD strain grew in the presence of the azole antifungals fluconazole and miconazole but was highly sensitive to heat shock, cell wall stress, and the echinocandin caspofungin. It was also unable to sustain filamentous growth and showed reduced virulence in a Caenorhabditis elegans infection model. RNA sequencing revealed only modest changes to the steady-state transcriptome of ire1{Delta}LD cells. Together, these findings define a differential requirement for the input domains of C. albicans Ire1, uncoupling growth under azole-induced membrane stress from the cell wall, thermal, and virulence-associated outputs that depend on proteotoxic sensing, a distinction that could inform antifungal strategies targeting the UPR.

Related

  1. Microbial Crosstalk in the Neonatal Gut: Candida albicans Impacts Group B Streptococcus Pathogenicity
    A. K. Lindon, A. N. Pearah, K. Dominguez +8
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  2. Contrasting defensive strategies underlie differential susceptibility of corals to crown-of-thorns sea star (CoTS; Acanthaster cf. solaris ) predation
    Lucy Gorman, Stella Caon, Ariana Huffmyer +4
    HALPreprintCC BY-NCEcologyHAL
  3. Differential Biofilm Susceptibility and Potent Isavuconazole Post-Antifungal Effect Distinguish Cutaneotrichosporon dermatis from Trichosporon asahii
    T. Yoshinouchi, T. Nakamura, D. Mori +2
    bioRxivPreprintCC BYFull textMicrobiologybioRxiv
  4. Dietary fiber-type-specific gut microbiome preconditioning drives differential susceptibility to sporadic colon cancer development
    S. Tian, S. Rajakaruna, G. Yalavarthi +10
    bioRxivPreprintCC BY-NCFull textMicrobiologybioRxiv
  5. Differential expression of NEAT1 in the corneal endothelium increases susceptibility to oxidative stress in Fuchs Endothelial Corneal Dystrophy
    N. Dhupar, J. Yan, N. Little +1
    bioRxivPreprintCC BY-NC-NDFull textCell biologybioRxiv
BibTeX
@misc{stackcouture2026differential,
  title = {{Differential requirement for the Ire1 luminal domain in Candida albicans drug susceptibility and pathogenicity}},
  author = {S. Stack-Couture and N. Towriss and I. Skulska and A. Kalabina and J. Genereaux and V. Dumeaux and R. S. Shapiro and P. Lajoie},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.24.753484},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.24.753484v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Differential requirement for the Ire1 luminal domain in Candida albicans drug susceptibility and pathogenicity
AU  - S. Stack-Couture
AU  - N. Towriss
AU  - I. Skulska
AU  - A. Kalabina
AU  - J. Genereaux
AU  - V. Dumeaux
AU  - R. S. Shapiro
AU  - P. Lajoie
PY  - 2026
DA  - 2026/09/24
PB  - bioRxiv
DO  - 10.64898/2026.09.24.753484
UR  - https://www.biorxiv.org/content/10.64898/2026.09.24.753484v1
AB  - The opportunistic human pathogen Candida albicans depends on the unfolded protein response (UPR) for cell wall integrity, antifungal tolerance, filamentous growth, and virulence. The UPR is driven by the conserved transmembrane sensor Ire1, which is activated either by misfolded proteins through its luminal domain or by lipid bilayer stress (LBS) through its transmembrane domain. In budding yeast, these two activation modes deploy divergent transcriptional programs. Whether the requirement for these two input domains is separable in C. albicans, where the cell membrane and cell wall are themselves the targets of major antifungal drug classes, remains unknown. Here, we engineered a C. albicans strain expressing Ire1 lacking an intact luminal domain (ire1{Delta}LD), which no longer detects proteotoxic stress. The ire1{Delta}LD strain grew in the presence of the azole antifungals fluconazole and miconazole but was highly sensitive to heat shock, cell wall stress, and the echinocandin caspofungin. It was also unable to sustain filamentous growth and showed reduced virulence in a Caenorhabditis elegans infection model. RNA sequencing revealed only modest changes to the steady-state transcriptome of ire1{Delta}LD cells. Together, these findings define a differential requirement for the input domains of C. albicans Ire1, uncoupling growth under azole-induced membrane stress from the cell wall, thermal, and virulence-associated outputs that depend on proteotoxic sensing, a distinction that could inform antifungal strategies targeting the UPR.
ER  -